Laura Mccurdy, M.D.
NPI 1336309491 · Obstetrics & Gynecology Physician · Jensen Beach, FL
Enrolled with Medicare as Practitioner - Obstetrics/Gynecology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1336309491
- Entity type
- Individual
- Primary specialty
- Obstetrics & Gynecology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- No
- License
- 2012-01020 (NC)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
18 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,269 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Screening 3d Breast Mammography77063 | 293 | $54 |
| Screening Mammography77067 | 291 | $132 |
| Cervical Or Vaginal Cancer Screening; Pelvic and Clinical Breast ExaminationG0101 | 159 | $42 |
| Screening Papanicolaou Smear; Obtaining, Preparing and Conveyance of Cervical Or Vaginal Smear to LaboratoryQ0091 | 117 | $46 |
| Automated Urinalysis Test81003 | 79 | $2 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 66 | $95 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 15 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Estradiol | 170 | 70 |
| Mirabegronbrand: Myrbetriq | 82 | 16 |
| Estradiolbrand: Estradiol (twice Weekly) | 38 | — |
| Progesterone, Micronizedbrand: Progesterone | 32 | — |
| Clotrimazole/Betamethasone Dipbrand: Clotrimazole-Betamethasone | 28 | 18 |
| Estrogens, Conjugatedbrand: Premarin | 28 | — |
| Clobetasol Propionate | 25 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$258 across 11 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2008-06-12
- Last updated
- 2013-04-10
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.